XML 56 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation - Stock option activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Shares Available for Grant      
Available and Outstanding as of beginning of year 3,538,268    
2022 Plan annual increase 1,917,456    
Granted (2,170,299)    
Forfeited 1,286,494    
Available and Outstanding as of ending of year 4,571,919   3,538,268
Number of Shares Outstanding      
Available and Outstanding as of beginning of year 10,081,915    
Granted 2,170,299    
Exercised (451,020)    
Forfeited (1,286,494)    
Available and Outstanding as of ending of year 10,514,700   10,081,915
Vested and exercisable 5,819,297    
Weighted Average Exercise Price      
Available and Outstanding as of beginning of year $ 3.11    
Granted 1.01    
Exercised 0.58    
Forfeited 4.37    
Available and Outstanding as of ending of year 2.63   $ 3.11
Vested and exercisable as of ending of year $ 2.39    
Weighted Average Remaining Contractual Life (Years)      
Outstanding as of ending of year 7 years 5 months 23 days   7 years 7 months 9 days
Vested and exercisable as of ending of year 6 years 3 months 25 days    
Aggregate Intrinsic Value      
Aggregate Intrinsic Value, outstanding $ 466   $ 4,098
Vested and exercisable $ 122    
Weighted average grant date fair value of options granted $ 0.55    
Share based payment award shares options exercise 451,020 374,432  
Fair value of the shares subject to stock options vested $ 2,400 $ 1,400  
Unamortized stock-based compensation expense $ 6,400    
Vesting term (in years) 1 year 10 months 13 days